Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology
Disease Category: Obesity
Trial Information
Behavioral modifications and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
A 52-Week, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients with Type 2 Diabetes Mellitus Managed with Oral Hypoglycemic Agent(s)
The MGH Weight Center is now enrolling for a new clinical trial for the treatment of diabetes and obesity!
You may be eligible to take part in a clinical research study with an experimental drug for the treatment of diabetes and obesity. This medication has shown to help short-term (12-week) weight loss in previous studies and will be tested to determine effectiveness for long-term weight loss.
The study will run for 64 weeks. Study related exams and drug as well as periodic nutritional counseling will be provided free of charge for those who qualify. Remuneration of up to $700 will also be provided.
The study will consist of:
•taking a study drug or placebo (sugar pill - no active medicine or drug ) for 1 year
If you take part in this study, you may not get the study drug
•individual nutritional counseling
•monthly visits to the MGH Weight Center to meet with the study team and dietitian
Eligible subjects must:
•be between the ages of 18 and 65
•have Type-II diabetes
•be overweight
•willing and able to commit to the study and taking the medication (or placebo) for 1 year
Institution – Massachusetts General Hospital, Boston, MA
Principal Investigator – Lee M. Kaplan, MD, PhD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name – Anna Moseman, Study Coordinator
Email – amoseman@partners.org
Phone – 617-724-9616
Anna C Moseman, CRC
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-724-9616
EMail: amoseman@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
